M. Nishi et al., THE RELATIONSHIP BETWEEN HOMOVANILLIC VANILLYLMANDELIC ACID RATIOS AND PROGNOSIS IN NEUROBLASTOMA/, Oncology Reports, 5(3), 1998, pp. 631-633
A total of 44 cases with neuroblastoma cases (excluding true positive
cases detected in mass screenings) who were born from 1979 to 1991, an
d had data concerning the clinical stage and values of vanillylmandeli
c acid (VMA) and homovanillic acid (HVA) at diagnosis (mu g/mg creatin
ine) were followed up until the end of 1994. Deaths were confirmed usi
ng the record of vital statistics of the Hokkaido Government. The 60-m
onth survival rate of those who had an HVA/VMA ratio of 1-2 was 80.0%.
Conversely, those with ratios <1 or >2 had respective survival rates
of 24.1% and 5.3%. Most of those with a ratio >2 died within 24 months
of diagnosis. Many of the cases with a ratio <1 lived over 12 months
but died within about 36 months. Many tumors of those cases with a rat
io of 1-2 originated in extraadrenal glands, and had negative n-myc am
plification. Most of the patients with a ratio >2 were diagnosed at 1
year of age or older. The HVA/VMA ratio at diagnosis is useful in esti
mating both the survival period and the prognosis.